NDC 54868-5113 Triamterene And Hydrochlorothiazide

View Dosage, Usage, Ingredients, Routes, UNII

Product Information

This product is EXCLUDED from the official NDC directory because the listing certification is expired.
NDC Product Code:
54868-5113
Proprietary Name:
Triamterene And Hydrochlorothiazide
Product Type: [3]
EXPIRED PRODUCT and EXCLUDED from the NDC Directory
Labeler Name: [5]
Physicians Total Care, Inc.
Labeler Code:
54868
Start Marketing Date: [9]
10-06-2004
Listing Expiration Date: [11]
12-31-2017
Exclude Flag: [12]
E
Code Structure:
Code Navigator:

Product Characteristics

Color(s):
WHITE (C48325 - WHITE CAPSULES WITH SINGLE BLACK INK BANDS)
Shape:
CAPSULE (C48336)
Size(s):
14 MM
Imprint(s):
GG;606
Score:
1

Product Packages

NDC Code 54868-5113-0

Package Description: 100 CAPSULE in 1 BOTTLE

NDC Code 54868-5113-1

Package Description: 30 CAPSULE in 1 BOTTLE

Product Details

What is NDC 54868-5113?

The NDC code 54868-5113 is assigned by the FDA to the product Triamterene And Hydrochlorothiazide which is product labeled by Physicians Total Care, Inc.. The product's dosage form is . The product is distributed in 2 packages with assigned NDC codes 54868-5113-0 100 capsule in 1 bottle , 54868-5113-1 30 capsule in 1 bottle . This page includes all the important details about this product, including active and inactive ingredients, pharmagologic classes, product uses and characteristics, UNII information and RxNorm crosswalk.

What are the uses for Triamterene And Hydrochlorothiazide?

This fixed combination drug is not indicated for the initial therapy of edema or hypertension except in individuals in whom the development of hypokalemia cannot be risked.Triamterene and hydrochlorothiazide capsules are indicated for the treatment of hypertension or edema in patients who develop hypokalemia on hydrochlorothiazide alone.Triamterene and hydrochlorothiazide capsules are also indicated for those patients who require a thiazide diuretic and in whom the development of hypokalemia cannot be risked.Triamterene and hydrochlorothiazide may be used alone or as an adjunct to other antihypertensive drugs, such as beta-blockers. Since triamterene and hydrochlorothiazide may enhance the action of these agents, dosage adjustments may be necessary.

Which are Triamterene And Hydrochlorothiazide UNII Codes?

The UNII codes for the active ingredients in this product are:

Which are Triamterene And Hydrochlorothiazide Inactive Ingredients UNII Codes?

The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:

What is the NDC to RxNorm Crosswalk for Triamterene And Hydrochlorothiazide?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:
  • RxCUI: 198314 - triamterene 50 MG / hydroCHLOROthiazide 25 MG Oral Capsule
  • RxCUI: 198314 - hydrochlorothiazide 25 MG / triamterene 50 MG Oral Capsule
  • RxCUI: 198314 - HCTZ 25 MG / triamterene 50 MG Oral Capsule
  • RxCUI: 198316 - hydroCHLOROthiazide 25 MG / triamterene 37.5 MG Oral Capsule
  • RxCUI: 198316 - hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Capsule

* Please review the disclaimer below.

Product Footnotes

[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.

[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.

[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.

[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".